CurrentRheuma
Get Weekly

Rheumatology journalCurrentRheuma coverage

RMD Open

What CurrentRheuma has captured from this journal. The coverage figures describe CurrentRheuma's coverage, not the journal's output. Figures as of 14 November 2026.

CurrentRheuma holds 899 Briefs from RMD Open, most often cohort studies and cross-sectional studies.

Recent
34 Briefs
past 90 days
Archive
899 Briefs
research published from January 2023 to today
Editorial
–
no Weekly issue published yet

Topics

Evidence types

Shares are of the 899 Briefs CurrentRheuma has covered from RMD Open, by primary topic and study type; a Brief without a primary topic is in no topic row.

Publication activity

Latest from RMD Open

All coverage, newest first

  1. RMD Open

    Early life infections, antibiotics and later risk of juvenile idiopathic arthritis: evidence from two Scandinavian birth cohorts with exploratory genetic analyses

    Meta-analysisPediatric

  2. RMD Open

    Clinical characteristics, inflammatory biomarkers and genetic background of patients with non-hereditary periodic fever syndromes

    Cohort studyAutoinflammatory & rare

  3. RMD Open

    Clinical phenotype, disease burden and inter-regional heterogeneity of axial spondyloarthritis in 1112 patients across 15 Arab countries: the PROSPA study

    Cross-sectional studySpondyloarthritis & PsA

  4. RMD Open

    Assessing vasculitis in Takayasu arteritis by ultrasound: results of OMERACT patient-based reliability exercises

    Research articleVasculitis & PMR

  5. RMD Open

    Frequency and predictors of disease progression in contemporary ACPA-negative undifferentiated arthritis in a treated-to-target early arthritis clinic

    Research articleRA

  6. RMD Open

    Better After CHoosing in rheumatoid arthritis (the BACH trial): patients who have the opportunity to choose their treatment are more satisfied

    Randomized controlled trialRA

  7. RMD Open

    Effectiveness of second-line biologics in juvenile idiopathic arthritis: the IIBIOJIA Study

    Cohort studyPediatric

  8. RMD Open

    First trimester exposure to hydroxychloroquine during pregnancy and major congenital malformations: a systematic review and meta-analysis

    Meta-analysisLupus & APS

  9. RMD Open

    Transformative improvement with staggered gains in rheumatoid arthritis remission and sustained remission, but higher relapse rates: a population-based cohort study from 1990 to 2019

    Cohort studyRA

  10. RMD Open

    Real-world association of biologic and targeted synthetic DMARD use with mortality in rheumatoid arthritis-associated interstitial lung disease: a nationwide cohort study

    Cohort studyRA

  11. RMD Open

    Synovial fluid cell isolation protocol affects immune cell recovery and composition across inflammatory states

    Research articleAcross diseases

  12. RMD Open

    Does weather matter? Exploring associations between season and meteorological factors and psoriatic arthritis disease activity

    Cohort studySpondyloarthritis & PsA

  13. RMD Open

    Partial bone erosion repair is independently associated with functional improvement in early rheumatoid arthritis: a 2-year prospective high-resolution peripheral quantitative CT (HR-pQCT) longitudinal study

    Cohort studyRA

  14. RMD Open

    Comparative analysis of instruments measuring peripheral arthritis activity in Spondyloarthritis: a measurement properties study in 13 RCTs

    Meta-analysisSpondyloarthritis & PsA

  15. RMD Open

    Comparison of four clinical risk prediction models for the diagnosis of giant cell arteritis: results from the ongoing PREDICT-GCA study

    Diagnostic or prognostic studyVasculitis & PMR

  16. RMD Open

    Risk of new primary cancer, locoregional progression or metastasis associated with bDMARDs and tsDMARDs in patients with rheumatoid arthritis and prior cancer: insights from the ARCA registry

    Cohort studyRA

  17. RMD Open

    Clinical and immunological outcomes of rituximab-based, mycophenolate mofetil-based and cyclophosphamide-based treatment strategies for systemic lupus erythematosus with active kidney involvement from LOOPS registry

    Cohort studyLupus & APS

  18. RMD Open

    Predicting disease flares in axial spondyloarthritis using different machine learning models in the METEOR-SpA registry

    Diagnostic or prognostic studySpondyloarthritis & PsA

  19. RMD Open

    Risk of cognitive disorders in patients with primary Sjögren’s disease: data from Korean Health Insurance Service

    Cohort studySjögren's & overlap

  20. RMD Open

    Association between initial treatment strategy and progression to difficult-to-treat rheumatoid arthritis (D2T-RA): evidence from a 20-year-old real-world cohort

    Cohort studyRA

  21. RMD Open

    Evaluating a guideline-aligned prednisone threshold within the Lupus Low Disease Activity State (LLDAS): associations with damage accrual

    Cohort studyLupus & APS

  22. RMD Open

    Integrated serum proteomics and autoantibody analyses reveal a biomarker signature predictive of flare during biologic tapering in rheumatoid arthritis

    Secondary analysisRA

  23. RMD Open

    Early SLE may follow a fast comorbidity/multimorbidity trajectory associated with flare burden and glucocorticoid exposure

    Cohort studyLupus & APS

  24. RMD Open

    Distinct molecular signature in relapsed patients with ANCA-associated vasculitis

    Mechanistic studyVasculitis & PMR

  25. RMD Open

    Temporal evolution of synovial histopathology in rheumatoid arthritis across treatment periods: a large-scale analysis of 1770 surgical specimens using the Rooney score

    Cohort studyRA

  26. RMD Open

    Incidence, baseline-associated factors and burden of difficult-to-manage axial spondyloarthritis: a 10-year analysis of the DESIR cohort

    Cohort studySpondyloarthritis & PsA

  27. RMD Open

    Comparative evaluation of disease activity measures for adult-onset Still’s disease: a multicentre, retrospective, cohort study

    Cohort studyAutoinflammatory & rare

  28. RMD Open

    Factors associated with the effectiveness and safety of Janus kinase inhibitors in rheumatoid arthritis: an 8-year observational study from the JAGUAR Registry

    Cohort studyRA

  29. RMD Open

    Efficacy and safety of upadacitinib in patients with psoriatic arthritis and exposure to one anti-TNF: post hoc analysis of SELECT-PsA 2

    Secondary analysisSpondyloarthritis & PsA

  30. RMD Open

    Metabolic effects of GLP-1 receptor agonists in rheumatology patients and inflammatory outcomes: a single-centre retrospective cohort

    Cohort studyAcross diseases

  31. RMD Open

    Exploring possibilities towards PeRsonalIsed MEdicine in Rheumatoid Arthritis (PRIMERA): tailored modifications to standard treat-to-target management—a multicentre, randomised, open-label trial

    Randomized controlled trialRA

  32. RMD Open

    Associations between synovitis and radiographic osteoarthritis progression in the first carpometacarpal and interphalangeal joints: results from the Nor-Hand study

    Cohort studyOsteoarthritis

  33. RMD Open

    Prevalence and clinical relevance of anti-drug antibodies in psoriatic arthritis: a systematic review

    Meta-analysisSpondyloarthritis & PsA

  34. RMD Open

    Integration of synovial pathotypes and serum proteomic modules as determinants of disease progression and therapeutic response in early rheumatoid arthritis

    Cohort studyRA

  35. RMD Open

    Whole-blood coagulation and platelet dynamics identify differential prothrombotic states in patients with rheumatoid arthritis treated with JAK or TNF-ɑ inhibitors

    Cross-sectional studyRA

  36. RMD Open

    Ultrasound-based withdrawal of biologics in rheumatoid arthritis (RA-BioStop)

    Cohort studyRA

  37. RMD Open

    Influence of initial axial involvement on the phenotypic evolution of axial spondyloarthritis: 10-year data from the DESIR cohort

    Cohort studySpondyloarthritis & PsA

  38. RMD Open

    Therapeutic approaches for difficult-to-treat rheumatoid arthritis: a systematic literature review of current evidence

    Meta-analysisRA

  39. RMD Open

    Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica

    Cohort studyVasculitis & PMR

  40. RMD Open

    Prognostic value of antiphospholipid antibodies in pregnancy outcomes in systemic lupus erythematosus

    Cohort studyLupus & APS

All 899 Briefs in ExploreShowing the 40 most recently published